USE THE COVERAGE TOOL TO CHECK ACCESS FOR AJOVY IN YOUR AREA

AJOVY has a national coverage of 94% for commercially insured patients

To check coverage in your area by plan, enter your zip code below.

commercial

medicaid

medicare

all

Payer name

Status

AJOVY is available through formulary exception with Medicare. If you need assistance with this
process, please see our section dedicated to your patients with Medicare part D.

Not all payer options are listed. Please confirm with your patient's insurance provider to see if AJOVY is covered.

Not all payer options are listed. Please confirm with your patient's insurance provider to see if AJOVY is covered. Please contact your local Teva representative to help you check the coverage for AJOVY in this area. Furthermore, Shared Solutions® is available to help your patients with financial assistance. They can start by registering with the Patient Services Portal.

The 3 largest commercial PBMs (CVS/Caremark, ESI, and OptumRx) now cover AJOVY as a preferred formulary choice for the preventive treatment of migraine.¹

Prior Authorization

Prior Authorization assistance is available through CoverMyMeds®. Visit CoverMyMeds.com or call 1-866-452-5017 Monday-Friday 8 AM–11 PM ET and Saturday 8 AM–6 PM ET.

Download Letter of Medical Necessity

Download Letter of Appeal

Contraindications: AJOVY® is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients. Reactions have included anaphylaxis and angioedema.

Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Most reactions were reported from within hours to one month after administration. Cases of anaphylaxis and angioedema have been reported in the postmarketing setting. If a hypersensitivity reaction occurs, consider discontinuing AJOVY and institute appropriate therapy.

Adverse Reactions: The most common adverse reactions in clinical trials (≥5% and greater than placebo) were injection site reactions.

AJOVY is indicated for the preventive treatment of migraine in adults.

Please see full Prescribing Information for AJOVY.

Reference: 1. Data on file. Parsippany, NJ: Teva Pharmaceuticals USA, Inc.